A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.

Inhalers that combine relieving breathlessness with preventing it seem to be the most effective option for reducing asthma ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their prescribed medications at a ...

AstraZeneca will launch a new online platform to make Airsupra, as well as Farxiga and Flumist, available for home delivery ...

AstraZeneca Plc (NASDAQ: AZN) launched AstraZeneca Direct, an online platform designed to create a simple, convenient way for ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...